Project

IP-001_RFA (IP-IIO-622): Intratumoral injection of IP-001 following thermal ablation in patients with advanced solid tumors. A multicenter Phase 1b/2a trial in colorectal cancer, non-small cell lung cancer, and soft tissue sarcoma patients

Completed - recruitment active · 2022 until 2024

Jörger Markus, Wittwer Yvonne, Quinter Janine